Morgan Stanley Maintains Overweight on Marathon Oil, Lowers Price Target to $26
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Devin McDermott has maintained an Overweight rating on Marathon Oil (NYSE:MRO) but lowered the price target from $27 to $26.
July 18, 2023 | 2:22 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Morgan Stanley has maintained an Overweight rating on Marathon Oil but lowered the price target from $27 to $26.
The news is directly about Marathon Oil. While the Overweight rating is maintained, indicating a positive outlook, the lowering of the price target might have a neutral to slightly negative impact on the stock in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100